TY - JOUR T1 - The unseen and pervasive threat of COVID-19 throughout the US JF - medRxiv DO - 10.1101/2020.04.06.20053561 SP - 2020.04.06.20053561 AU - Emily Javan AU - Spencer J. Fox AU - Lauren Ancel Meyers Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/18/2020.04.06.20053561.abstract N2 - Without a coordinated state or federal response to COVID-19 across the United States, counties are left to weigh the potentially large yet unseen threat of COVID-19 with the economic and societal costs of enacting strict social distancing measures. The immediate and long-term risk of the virus can be difficult to grasp, given the lack of historical precedent and that many cases go undetected. We calculated the risk that there already is sustained community transmission that has not yet been detected. Given the low testing rates throughout the country, we assume that one in ten cases are tested and reported. If a county has detected only one case of COVID-19, there is a 50% chance that there is already a growing outbreak underway. COVID-19 is likely spreading in 85% of all counties in the US, containing 96% of the national population. Proactive social distancing, even before two cases are confirmed, is prudent.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge the financial support from National Institutes of Health (grant no. U01 GM087719 and project no. 5T32LMO012414).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode to generate data available online. https://github.com/MeyersLabUTexas/COVID-19-Epidemic-Risk https://github.com/sjfox/rtZIKVrisk ER -